Equities

LadRx Corp

LADX:QBB

LadRx Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.80
  • Today's Change0.063 / 8.52%
  • Shares traded2.01k
  • 1 Year change+23.08%
  • Beta1.4261
Data delayed at least 15 minutes, as of Nov 22 2024 20:34 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects LadRx Corp share price to rise to 4.50 in the next year from the last price of 0.7372.
High510.4%4.50
Med510.4%4.50
Low510.4%4.50

Earnings history & estimates in USD

Earnings forecasts are not available for LadRx Corp. On Mar 27, 2020, LadRx Corp reported 4th quarter 2019 losses of -- per share.
Average growth rate+28.57%
Annual earnings information is not available for LadRx Corp.
Average growth rate+35.05%
More ▼

Revenue history & estimates in USD

CytRx Corporation did not report revenues for the full year 2019. However, during the prior year the company reported revenues of 250.00k.
Average growth rate0.00%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.